Precise and rapid release of X-ray activated autophagy inhibitors for radiotherapy sensitization of hypopharyngeal carcinoma

Read full text Summarise with VIRAT
Authors: Xinyuan Luo, Rui Rong, Jiao Zhou, Qiongling Huang, Yanjun Huang, Xiaofang Chen, Ming Lu, Shenjiong Ruan, Kehui Chen, Yuanchang Zhou, Zexin Li, Jiwang Zhang
+2 more Yun Zhang, Chaohui Zheng
Cited by: 0
References: 61

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Protective autophagy represents a major factor responsible for radiotherapy resistance in tumor cells, leading to therapeutic failure, metastasis, and recurrence. Autophagy inhibitors can enhance radiosensitivity by suppressing protective autophagy in tumor. However, the usage of autophagy inhibitors is limited by the issues including non-specific release and delayed delivery. In this work, we develop an X-ray-activatable nanocarrier ZGGC@MON-CQ (ZMC) for precise and rapid release of autophagy inhibitors in tumor cells which enables significantly enhanced radiosensitization. The designed ZMC can precisely probe tumors via background-free fluorescence under the guidance of afterglow of high signal-to-noise ratio 50.7 which specifically enhanced by the tumor microenvironment (TME). Under X-ray irradiation, the tetrasulfide-incorporated mesoporous silica coating on the surface of afterglow nanoparticle undergoes cleavage, leading to rapid release of the autophagy inhibitors (50% released within 30 minutes). The efficient release is facilitated by a highly active redox-cleavage reaction between the tetrasulfide bonds and the abundant H 2 O 2 generated by X-ray excitation in the mildly acidic condition of TME. In animal models, the ZMC exhibit highly effective radiosensitization in hypopharyngeal carcinoma that is highly dependent on radiotherapy. This work overcomes the limitations of conventional drug delivery systems, such as off-target release and slow response (e.g., glutathione (GSH)-triggered release exceeding 6 hours), and offers a new strategy for precise and rapid delivery of autophagy inhibitors.

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Nanoparticle-Based Drug Delivery Radiation Therapy and Dosimetry

Publication details

Journal / source
Materials Today Bio
Volume
38
Pages
103070–103070
Publication date
25 March 2026
Language
EN